Recherche avancée

Rachel A. Stahler est membre du conseil d'administration de NeoGenomics, Inc. et de NeoGenomics Laboratories, Inc. Dans le passé, elle a occupé les postes de directrice de l'information d'inVentiv Health Clinical, Inc. et d'Optimer Pharmaceuticals LLC, de directrice de l'information d'inVentiv Health, Inc. et de directrice de l'information d'InVentiv Group Holdings, Inc. Elle est titulaire d'un MBA de The Trustees of Columbia University dans la ville de New York et d'un diplôme de premier cycle de l'université de Pennsylvanie.

Cord F. Sthler a fondé febit holding GmbH. Il occupe le poste de président chez Hummingbird Diagnostics GmbH et de directeur de la technologie chez Dentsply Sirona, Inc. Dans le passé, il a occupé le poste de directeur général de febit holding GmbH et de président et directeur général de Febit, Inc. (une filiale de febit holding GmbH) et directeur du Fraunhofer-Institut fr Offene Kommunicationssysteme.

Actuellement, Rachel Bernadette Addison occupe le poste de directeur financier chez Future Plc. Elle siège également au conseil d'administration de 8 autres sociétés. Au cours de sa carrière, Mme Addison a été directrice financière du Nottingham Post Group, directrice exécutive du groupe des finances et des opérations de DMGZ Ltd, directrice de l'exploitation et des finances de Local World Ltd, directrice des finances et du développement du marché de Reckitt Benckiser Healthcare International Ltd, directrice principale d'Arthur Andersen LLP et directrice des risques stratégiques de Boots the Chemists Ltd.

Mme Rachel Mittelman est directrice de l'information chez Azrieli Group Ltd. Elle a obtenu son diplôme de premier cycle à l'université de Tel-Aviv et un MBA à l'université de Tel-Aviv.

Rachel Marie Ruggeri is currently an Independent Director at Stryker Corp.
since 2024.
She is also currently serving as the Executive VP, Chief Financial & Accounting Officer at Starbucks Corp.
since 2001.
Previously, she worked as the Chief Financial Officer & Senior Vice President at The Krusteaz Co. from 2018 to 2020.
Rachel also held a position as a Member-Supervisory Board at President Starbucks Coffee (Shanghai) Co., Ltd.
In terms of education, Ms. Ruggeri completed her undergraduate degree at the University of Puget Sound and obtained an MBA from Washington State University.

Actuellement, Rachel Frances Tongue occupe les postes de directeur financier et directeur de Games Workshop Group Plc et de directeur général de Games Workshop Deutschland GmbH, de secrétaire et directeur de Games Workshop US (Holdings) Ltd, de secrétaire et directeur de Games Workshop International Ltd, de secrétaire et directeur de Games Workshop US Ltd et de secrétaire et directeur de Games Workshop Ltd. (qui sont toutes des filiales de Games Workshop Group Plc).

Actuellement, Rachel C. Glaser occupe le poste de directeur financier chez Etsy, Inc. Mme Glaser est également membre du conseil d'administration de The New York Times Co. Mme Glaser a précédemment occupé le poste de vice-présidente des opérations et de la planification commerciale chez The Walt Disney Co. et celui de directrice des opérations et des finances de MyLife.com, Inc. et de directrice des opérations et des finances de Reunion.com, Inc. (filiale de MyLife.com, Inc.), directeur financier de Leaf Group Ltd, directeur financier de Move, Inc. et premier vice-président des opérations financières de Yahoo ! Rachel C. Glaser est titulaire d'un diplôme de premier cycle de l'Université de Californie, Berkeley et d'un MBA de l'USC Marshall School of Business.

Rachel Meyers is the founder of Faze Medicines, Inc. She is currently an Independent Director at Korro Bio, Inc. since 2023.
Previously, she worked as a Senior Scientist at Millennium Pharmaceuticals, Inc. from 1993 to 2003.
Additionally, she held the position of Vice President-Research & RNAi Lead Discovery at Alnylam Pharmaceuticals, Inc. from 2011 to 2013.
Dr. Meyers obtained a doctorate degree from the Massachusetts Institute of Technology and an undergraduate degree from Brandeis University.

Rachel Wilson occupe le poste de directeur financier, trésorier et vice-président exécutif chez R1 RCM, Inc. Dans le passé, Mme Wilson a occupé le poste de directrice financière des centres de données et de vice-présidente chez Iron Mountain, Inc. et de vice-présidente du développement de l'entreprise et des relations avec les investisseurs chez Jarden Corp. Elle a obtenu un MBA à la Columbia Business School, un diplôme d'études supérieures à la Paul H. Nitze School of Advanced International Studies (IT) et un diplôme de premier cycle et un diplôme d'études supérieures à l'Atlantic Basin Policy Institute de l'université John Hopkins.

Actuellement, Rachel Clare Empey est directrice financière de Fresenius SE & Co. KGaA, directrice financière de Fresenius Management SE et directrice financière de Telefnica Germany Management GmbH. Mme Empey est également membre du conseil d'administration de Fresenius Kabi AG et de Fresenius Medical Care Management AG et membre de l'Institute of Chartered Accountants in England & Wales. Au cours de sa carrière, Mme Empey a été directrice financière et stratégique de Telefnica Deutschland Holding AG, directrice financière de Telefnica UK Ltd, directrice commerciale de Weir Strachan & Henshaw UK, vice-présidente du contrôle de gestion de Telefnica Germany GmbH & Co. OHG, contrôleur de groupe chez Telefnica Europe Plc et auditeur chez Ernst & Young GmbH. Rachel Clare Empey a obtenu un diplôme d'études supérieures du St. Hilda's College et un diplôme d'études supérieures de l'Université d'Oxford.

Mr. Doug Stahler is a Manager-Reliable Airflow at Hyduke Energy Services, Inc.

Christoph Stahler is currently the Head of the Trust & Depositary Business in Germany at The Bank of New York Mellon Corp.
He previously held the position of Head of the Trust & Depositary Business at the same company.

David Stahler has been President, Treasurer, Secretary and a Director of Florham Consulting Corp.
since 2006.

Ralf Stähler is currently the Co-Managing Director at Schnorrenberg Chirurgiemechanik GmbH and Hospigate GmbH.
Previously, he served as a Member-Management Board at Rhön-Klinikum AG from 2005 to 2010 and also held a position on the Member-Management Board at Cheminova Deutschland GmbH & Co. KG.

Harold Stahler currently works as a Director at Goulston & Storrs PC.

Rachel Ofer worked as the Director of Human Resources Planning & Development at Tadiran Ltd.
from 1984 to 1988.
She earned a Master's in Business Administration from Tel-Aviv University in 1980 and an undergraduate degree from the same university in 1976.

Rachel M.
Rowe is currently the Director at Southern New Hampshire Medical Center.
Prior to this, she worked as Vice Chairman at Concord Hospital, Inc.

Rachel Hines is currently the Co-Chairman at TechnoServe, Inc. and a Trustee at Sesame Workshop.
Previously, she worked as a Managing Director at JPMorgan Chase & Co. and as a Member at the Council on Foreign Relations, Inc.

Ms. Rachel B.
Dalton is a Portfolio Manager at JPMorgan Investment Management, Inc. Ms. Dalton was previously employed as an Analyst by C.
E.
Unterberg, Towbin, Inc., a Principal by CIBC Oppenheimer Advisers LLC and a Senior Analyst by Acharne Capital Management LLC.
She received her Bachelor of Arts in Urban Planning and Economics from Columbia University and a Master of Business Administration from New York University Stern School of Business.

Rachel Garbow Monroe currently works at The Harry & Jeanette Weinberg Foundation, Inc., as President & Chief Executive Officer from 2010 and Baltimore Gas & Electric Co., as Independent Director from 2023.

Rachel H.
Ross is currently a Director at Medical Mutual Insurance Co. of North Carolina.
She was previously a Director at Curi Holdings, Inc.

Rachel Lambert is an Investor Relations Manager and oversees and manages a global contact programme of meetings with investors.
Based in London, Rachel joined Apax Partners in 2005 and has been involved in the preparation phase and fundraising process of each fund since Apax Europe VII.
Prior to joining Apax Partners, Rachel was an Investor Relations Manager at Baring Private Equity Partners (BPEP), a firm specialising in growth funds in emerging markets.
She worked at BPEP for 12 years both in contact management and in the management of a global PR programme.
Rachel began her career in the Training and Development department of the London Stock Exchange.
Rachel holds a BA in Latin from Bristol University and a Postgraduate Diploma in Vocal Training from the Guildhall School of Music and Drama.

Rachel Blatt is Vice President of Marketing for Vinfolio, Inc. She joined Vinfolio 2006.
Ms. Blatt rejoined MyPoints.Com as Director of Marketing in 2005.
She co-founded Vie Winery in 2004.
Ms. Blatt joined USWeb/CKS in 1998 as an Account Manager.
She joined MyPoints.com in 1999 and served until 2002.
Ms. Blatt received a BA degree in History from Emory University in Atlanta.

Ms. Rachel Miu is an Analyst at DBS Vickers (Hong Kong) Ltd.
Ms. Miu was previously employed by Aegis Portfolio Managers Pte Ltd.
and by Daiwa Securities (HK) Ltd., and an Associate Director & Deputy Head of Research by Kingsway Financial Services Group Ltd.
(Research Firm).
She received her undergraduate degree from National University of Singapore.

Rachel R.
Stern is currently serving as Vice Chairman-Friends Board at Neuberger Museum of Art, Vice Chairman at The Baldwin School, Director at Westchester, Director at Morrow Sodali Global LLC, Director at Morrow Sodali Pty Ltd., and Treasurer at American Foundation for the Courtauld Institute of Art.
Previously, she worked as Principal at Cravath, Swaine & Moore LLP, Secretary, Chief Legal Officer & EVP at FactSet Research Systems, Inc., and Secretary at FactSet Europe Ltd.
Ms. Stern holds a graduate degree from the University of London, an undergraduate degree from Yale University, and a graduate degree from The University of Pennsylvania Law School.

Rachel Kyllo currently works at Kemps LLC, as Vice President-Marketing and International Ice Cream Association, as Secretary from 2010.

Ms. Rachel M.
Zibrak is a Senior Wealth Advisor & Portfolio Manager at The Colony Group LLC.
Ms. Zibrak is responsible for providing clients with investment management and financial planning services.
She conducts research on both public and private market strategies and communicates the firm’s investment offerings to advisors and clients.
She participates in the development of the firm’s asset allocation policy and contributes to portfolio construction.
Ms. Zibrak served as Director of Research and Senior Financial Planner at Derby and Company, Inc. prior to their merger with The Colony Group in 2021.
Previously, she spent five years as a Senior Research Analyst at RINET.
She also held Senior Research Analyst positions at New England Private Wealth Advisors and Kobren Insight Management.
She started her career at Fidelity Investments.
Ms. Zibrak earned her Master of Business Administration from Boston College and her Bachelor of Science in Finance from Lehigh University.

Rachel K.
King is the founder of GlycoMimetics, Inc. (founded in 2003) and currently holds the position of Director.
She is also currently serving as an Independent Director at Novavax, Inc. since 2018.
Additionally, Ms. King is a Director at MdBio, Inc., University of Maryland Biopark, and Learning Undefeated, Inc. In her former positions, Ms. King served as the Chief Executive Officer of Genetic Therapy, Inc. from 1996 to 1998.
She also held the role of President, Chief Executive Officer & Director at Biotechnology Innovation Organization from 2022 to 2024.
Furthermore, Ms. King was a Director at Warp Drive Bio, Inc. and Executive Vice President at ALZA Corp.
She also worked as a Senior Vice President at Novartis Corp.
from 1999 to 2001 and as a Principal at Bain & Co., Inc. Ms. King was a Principal at NEA Management Co. LLC from 2009 to 2012.
Ms. King completed her undergraduate studies at Dartmouth College and holds an MBA from Harvard Business School.

Ms. Rachel Beck is Vice President at Morgan Joseph TriArtisan LLC.
Prior to joining Morgan Joseph in April 2010, she was a Vice President at Enclave Capital LLC and also at Broadpoint Capital, Inc., where she was responsible for the evaluation and execution of various types of financings including PIPES, Registered Directs and late-stage venture financings.
Her deal experience includes companies in the healthcare, technology and energy/alternative energy sectors.
Before joining Broadpoint, she was also associated with UBS Warburg and JP Morgan.
Ms. Beck holds a Bachelor of Science degree from Cornell University.

Rachel Cohen-Shalom worked as the Vice President-Operations at Synel M.L.L.
Payway Ltd.
from 1995 to 2018.
She obtained an undergraduate degree from The Open University of Israel.

Rachel Braun Scherl was the founder of Semprae Laboratories, Inc. which was founded in 2008 where she held the title of President from 2008 to 2010.
She is currently a Director at Formula XO, Inc. Ms. Scherl's former jobs include being a Principal at American Express Co., Johnson & Johnson, Disney Ltd., Marketing Corp.
of America, and McNeil Consumer & Specialty Pharmaceuticals, Inc. Ms. Scherl received her undergraduate degree from Stanford University in 1992.

Rachel Lomas has worked as a Manager-Australian National Sales at Ecoya Pty Ltd.
since 2008.